Elacestrant: who are optimal candidates for the first oral SERD? Lipsyc-Sharf M, Tolaney SM. Ann Oncol 2023;34:449-451.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lipsyc-Sharf M, Tolaney SM. Elacestrant: who are optimal candidates for the first oral SERD? Ann Oncol 2023;34:449-451.
PMID: 36813113